{"data":{"id":748,"citation":"Tahara A, Kurosaki E, Yokono M, Yamajuku D, Kihara R, Hayashizaki Y, Takasu T, Imamura M, Qun L, Tomiyama H, Kobayashi Y, Noda A, Sasamata M, Shibasaki M.: Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol, Volume 385 (4), 2012","title":"Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.","doi":"10.1007\/s00210-011-0713-z","doi_url":"https:\/\/doi.org\/10.1007\/s00210-011-0713-z","pmid":"22139434","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/22139434\/","year":2012,"journal":"Naunyn Schmiedebergs Arch Pharmacol","volume":"385","issue":"4","page":"423-436","authors":[{"first_name":"Hayashizaki Y","last_name":null,"full_name":null},{"first_name":"Imamura M","last_name":null,"full_name":null},{"first_name":"Kihara R","last_name":null,"full_name":null},{"first_name":"Kobayashi Y","last_name":null,"full_name":null},{"first_name":"Kurosaki E","last_name":null,"full_name":null},{"first_name":"Noda A","last_name":null,"full_name":null},{"first_name":"Qun L","last_name":null,"full_name":null},{"first_name":"Sasamata M","last_name":null,"full_name":null},{"first_name":"Shibasaki M.","last_name":null,"full_name":null},{"first_name":"Tahara A","last_name":null,"full_name":null},{"first_name":"Takasu T","last_name":null,"full_name":null},{"first_name":"Tomiyama H","last_name":null,"full_name":null},{"first_name":"Yamajuku D","last_name":null,"full_name":null},{"first_name":"Yokono M","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/748","landing_page":"https:\/\/molmedb.upol.cz\/publication\/748","created_at":"2020-08-24T06:50:45.000000Z","updated_at":null}}